Fielmann Group AG (FRA:FIE) ROCE %: 17.69% (As of Mar. 2026)


FRA:FIE Fielmann Group AG FRA:FIE
85 GF Score
Price €43.50
GF Value €53.73
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Fielmann Group AG ROCE %?

Fielmann Group AG FRA:FIE +0.69% 85 ROCE % is 17.69% as of Mar. 2026. GuruFocus rates FRA:FIE with a GF Score™ of 85/100 and a GF Value™ of €53.73 (Modestly Undervalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Fielmann Group AG's annualized ROCE % for the quarter that ended in Mar. 2026 was 17.69%.

Fielmann Group AG  (FRA:FIE) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Fielmann Group AG ROCE % Related Terms

Fielmann Group AG ROCE % Historical Data

* Premium members only.

The historical data trend for Fielmann Group AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fielmann Group AG ROCE % Chart

Fielmann Group AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.40 12.29 15.44 16.27 18.09

Fielmann Group AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.61 17.73 17.76 14.54 17.69
FRA:FIE
85GF Score
Fielmann Group AG FRA:FIE
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fielmann Group AG ROCE % Calculation

Fielmann Group AG's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=312.215/( ( (2381.299 - 846.714) + (2485.206 - 567.411) )/ 2 )
=312.215/( (1534.585+1917.795)/ 2 )
=312.215/1726.19
=18.09 %

Fielmann Group AG's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=339.176/( ( (2485.206 - 567.411) + (0 - 0) )/ 1 )
=339.176/( ( 1917.795 + 0 )/ 1 )
=339.176/1917.795
=17.69 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 17.69% mean?
Fielmann Group AG (FRA:FIE) has a ROCE % of 17.69% as of Mar. 2026.
Is Fielmann Group AG's ROCE % too high?
Fielmann Group AG's current ROCE % is 17.69%. The Medical Devices & Instruments industry median ROCE % is 2.23. Fielmann Group AG's value of 17.69% is 693.3% above this industry median. Overall, Fielmann Group AG has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fielmann Group AG's ROCE % compare to ISRG and BDX?
Fielmann Group AG's ROCE % of 17.69% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Fielmann Group AG's value of 17.69% is 693.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fielmann Group AG's current ROCE % of 17.69% is 693.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fielmann Group AG's current ROCE % is 17.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fielmann Group AG stock overvalued right now?
Based on GuruFocus' analysis, Fielmann Group AG (FRA:FIE) is currently considered Modestly Undervalued. The stock's GF Value™ is €53.73, compared to a current price of €43.50 — trading 19% below its estimated fair value. The current ROCE % is 17.69% and 693.3% above the Medical Devices & Instruments industry median of 2.23. Fielmann Group AG's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Fielmann Group AG (FRA:FIE), the current ROCE % is 17.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fielmann Group AG (FRA:FIE) Overvalued in 2026?

Based on GuruFocus' analysis, Fielmann Group AG stock appears to be undervalued. The current stock price of €43.50 is trading 19% below its estimated GF Value™ of €53.73. GuruFocus considers Fielmann Group AG to be Modestly Undervalued.

Key valuation signals for FRA:FIE:

  • ROCE %: 17.69%
  • GF Value™: €53.73 vs. price of €43.50 (19% below fair value)
  • GF Score™: 85/100 with 2 warning signs
  • Industry Position: 693.3% above the Medical Devices & Instruments median

No single metric tells the full story. See the FRA:FIE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fielmann Group AG Business Description

Address Fuhlsbuttler Strabe 399, Hamburg, DEU, 22309
Fielmann Group AG is involved in the purchase and sale of goods, in physical stores as well as wholesale and online, particularly in the optometric and hearing acoustics sectors, and especially sales of all kinds of vision aids - particularly glasses, eyeewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems, as well as personal protective equipment. Fielmann is involved in all levels of the optical industry value-added chain: designing, manufacturing, product offering, and optician services. The group was divided into six segments: Germany, Switzerland, Austria, Spain, North America, and Other. The majority of its revenue is generated from Germany.
85GF Score

Get the complete analysis for FRA:FIE

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€43.50
Price
€53.73
GF Value